Cough, Cold and Allergy (Hay Fever) Remedies in Georgia
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN GEORGIA
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Value Growth of Category Is Expected To Be Faster in Forecast Than Review Period
Antihistamines and Cough Remedies Benefit From Worsening Pollution
Cold Remedies Faces Competition From Analgesics
Competitive Landscape
GlaxoSmithKline Plc Remains Leading Gbo
Angelini Group Gbo Is Second in the Category
Presence of Local Manufacturer Is Quite Noticeable
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Executive Summary
Changes in Consumer Lifestyle Drive Growth of Consumer Health
Relative Stabilisation of Georgian Currency Brings Strong Value Growth
Local Manufacturers Slowly But Steadily Manage To Expand Sales Share
Emerging Areas of Consumer Health Support Variety of Distribution Channels
Consumer Health Is Expected To Maintain Positive Growth
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018
Market Data
Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Distribution of Consumer Health by Format: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format and Category: % Value 2018
Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources
The value performance of cough, cold and allergy (hay fever) remedies is expected to outpace that of the review period at constant 2018 prices. One of the reasons for this better performance will be a more stable economy. The review period saw waves of currency fluctuations; the Georgian lari experienced continued devaluation against the US dollar and euro. Georgia depends largely on imports, so that caused higher prices for imports and affected disposable incomes of consumers. That was an obsta...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Georgia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.